SH3BP2 and liver disorder: SYK in myeloid cells strongly suppresses the recruitment of infiltrating neutrophils and macrophages into the liver, and either 3BP2 deficiency or SYK deletion in myeloid cells shows therapeutic effects against liver inflammation, indicating the important position of SYK-3BP2 signaling pathway in the development of liver inflammatory diseases [24].